Phase I

With you from molecule to new medication – and every phase in between.

The first stages of a clinical trial can be tense. So, choosing a partner to share this critical phase of your drug’s journey is key. By working with us, you’ll gain a simplified and dedicated approach to initial stage testing.

Our early phase hospital-based units are already in place across three continents, meaning we can offer accelerated timelines and reduced expenses. In addition, our global SOPs are well established, so we’re ready to commit to Phase I clinical trials when you are.

To further support your development, our Quantitative Clinical Development solutions combine clinical pharmacology modeling and simulation with clinical PK/PD and pharmacometrics for a more strategic approach to clinical development.

But the most important thing we offer at this stage is an experienced team who recognize the time, technology and hope you’ve invested in your product so far, and are committed to taking it to the next phase.

First in Human

Learn more about our first-in-man - or first-in-human (FiH) - and other Phase I safety studies.

Learn More

Can Your Drug Development Journey Be Advanced With Genomic Medicine Expertise?

Read Article

Starting Stronger In Phase I Through IIA

Read Article

Validated Assays Methods

Read Article

Predicting Your Path To Approval

Read Article

Medical Writing Services

Read Article

We are always available for a conversation.

*